Table 2A.
Comparison of somatic hypermutation frequency in WAS patients and controls
Transcript | Homology (%) | Mutation frequency (%) | Unmutated sequences (%) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
WAS | Ctrl | p-value | WAS | Ctrl | p-value | WAS | Ctrl | p-value | ||
Adult CD21hiCD27+ |
Cγ VH3 | 94.35 ± 2.78 | 93.21 ± 2.16 | 0.0009 | 4.94 ± 2.87 | 6.31 ± 2.75 | 0.0002 | 13.98 ± 22.37 | 4.01 ± 8.68 | NS |
Cγ VH4 | 94.09 ± 2.85 | 92.77 ± 2.66 | 0.0009 | 5.26 ± 2.18 | 6.82 ± 2.55 | 0.0001 | 20.67 ± 22.36 | 0.617 ± 1.85 | 0.0149 | |
Children CD21hiCD27+ |
Cγ VH3 | 95.65 ± 2.97 | 94.00 ± 1.53 | 0.0007 | 3.51 ± 2.01 | 4.90 ± 1.78 | 0.0011 | 37.01 ± 28.89 | 0.00 | 0.0303 |
Cγ VH4 | 94.63 ± 2.97 | 94.83 ± 2.37 | NS | 4.47 ± 2.69 | 4.76 ± 2.22 | NS | 24.57 ± 15.10 | 6.06 ± 10.49 | 0.0190 |